【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hormone Sensitive Breast Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hormone Sensitive Breast Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hormone Sensitive Breast Cancer 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Hormone Sensitive Breast Cancer Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Hormone Sensitive Breast Cancer 33
Dec 07, 2011: Study Finds Anti-Estrogen Combo Better Than Single Drug For Hormone Sensitive Breast Cancer 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
GlaxoSmithKline plc 38
Clinical Trial Overview of GlaxoSmithKline plc 38
Mylan Inc. 39
Clinical Trial Overview of Mylan Inc. 39
Medivation, Inc. 40
Clinical Trial Overview of Medivation, Inc. 40
Cipla Ltd. 41
Clinical Trial Overview of Cipla Ltd. 41
Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Bluefish Pharmaceuticals AB 42
Clinical Trial Overview of Top Institutes / Government 43
Vanderbilt-Ingram Cancer Center 43
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 43
Japan Breast Cancer Research Group 44
Clinical Trial Overview of Japan Breast Cancer Research Group 44
Asan Medical Center 45
Clinical Trial Overview of Asan Medical Center 45
British Columbia Cancer Agency 46
Clinical Trial Overview of British Columbia Cancer Agency 46
Saitama Medical University 47
Clinical Trial Overview of Saitama Medical University 47
Institut Claudius Regaud 48
Clinical Trial Overview of Institut Claudius Regaud 48
Institut Bergonie 49
Clinical Trial Overview of Institut Bergonie 49
Institut Curie 50
Clinical Trial Overview of Institut Curie 50
Mayo Clinic 51
Clinical Trial Overview of Mayo Clinic 51
Five Key Clinical Profiles 52
Appendix 167
Abbreviations 167
Definitions 167
Research Methodology 168
Secondary Research 168
About GlobalData 169
Contact Us 169
Disclaimer 169
Source 170
【レポート販売概要】
■ タイトル：ホルモン感受性乳癌：世界の臨床試験レビュー（2014年上半期）■ 英文：Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014
■ 発行日：2014年3月19日
■ 調査会社：GlobalData
■ 商品コード：GDHC2040CTIDB
■ 調査対象地域：グローバル
- Glioblastoma Multiforme (GBM)：グローバル臨床試験レビューH2, 2013Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2013" provides data on the Glioblastoma Multiforme (GBM) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glioblastoma Multiforme (GBM). It includes an overv …
- Adams-Columbia Electric Cooperative：発電所及びSWOT分析2013Adams-Columbia Electric Cooperative - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) …
- 掘削廃棄物管理の世界市場：処理・廃棄、格納・ハンドリング、固形物制御The global drilling waste management market is expected to grow from USD 3.80 Billion in 2015 to USD 5.08 Billion by 2020, at a CAGR of 6.0%. North America accounted for the largest market share due to the abundance of the drilling activities created by the increase of the shale oil. Europe is projected to grow at the highest CAGR during the forecast period which can be attributed to the maturing …
- BRIC地域における人工心臓弁の市場動向（～2020）BRIC Prosthetic Heart Valves Market Outlook to 2020 Summary GlobalData’s new report, "BRIC Prosthetic Heart Valves Market Outlook to 2020", provides key market data on the BRIC Prosthetic Heart Valves market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Mechanical Heart Valves, Tissue Heart Valves and …
- 世界のクラウドサービス仲介市場In the increasingly complex cloud computing scenario, there exists a dire need to amalgamate all cloud-based services and offerings on an integrated platform, to ensure seamless delivery to the end-user. With a wide array of offerings spanning across infrastructure-as-a-service (IaaS), Software-as-a-service (SaaS), Platform-as-a-service (PaaS), Business Process as a Service (BPaaS), and many alike …
- ウェット型(新生血管型/滲出型)黄斑変性症の治療薬パイプライン動向（2015年上半期版）Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015’, provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exud …
- 世界の細胞培養装置及び消耗品市場（2014-2018）About Cell Culture Cell culture is the in vitro growth of plant or animal cells for several applications such as research, cell studies, and biopharmaceutical production. Cell culture is a crucial step in tissue engineering and vaccine production. Cell culture instruments and cell culture consumables are necessary for the in vitro production of cell lines. Some essential cell culture instruments a …
- 世界の食品乳化剤市場：ジグリセリド、レシチン、ソルビタンエステルなどThe global food emulsifiers market is a promising segment within the food ingredients market. Food emulsifiers market is considered to be fastest growing segment of food additives market due to the growing trend towards reducing fat content in food products. Though, the emulsifier market is largely driven by and di-glycerides and derivatives, lecithin, stearoyl lactylates, and other emulsifiers su …
- Global LTE Industry Landscape: Adoption, Applications, Deployments and Subscriptions by Region, Country, Spectrum and Operator 2011 – 2015While LTE adoption is moving at a much quicker pace than initial analyst expectations, a number of hurdles still exist that undermine the early adoption of LTE by many countries. Firstly the limitation of the frequency spectrum presents a major setback for many network operators, as majority of the spectrum bands suitable for LTE are yet to be fragmented in many regions. The 800 MHz 'digital divid …
- 表面実装（SMT）の世界市場：半田付け装置、スクリーン印刷装置、配置装置、検査装置、洗浄装置、修理装置The surface mount technology market was valued at USD 2.70 Billion in 2014 and is expected to grow at a CAGR of 9.84% between 2015 and 2020. The miniaturization of electronics product, primarily consumer products, and circuit boards with greater packaging density is driving the market. Using surface mount technology method, both layers of the PCBs could be used for assembling and the final PCB are …
- 世界のVoLTE市場：機会、課題、戦略、予測VoLTE (Voice over LTE) technology allows a voice call to be placed over an LTE network, enabling operators to reduce reliance on legacy circuit-switched networks. Powered by IMS (IP Multimedia Subsystem) architecture, VoLTE brings a host of benefits to mobile operators ranging from the ability to refarm legacy 2G and 3G spectrum to offering their subscribers a differentiated service experience thr …
- 中東（GCC）のセメント市場Technavio’s market research analyst has estimated the cement market in the GCC to post a healthy market growth rate of more than 6% during the forecast period. The rise in population, increase in tourists, demand for affordable houses, and the development of new cities are some of the factors that are expected to propel market growth during the forecast period. Augmented investments in the transpo …
- 音声認識ソフトの世界市場2016-2020About Speech Recognition Software A speech recognition software identifies words spoken by an individual or speaker into a microphone, converts them into a computer-readable format, and responds automatically. These software applications recognize speech in multiple languages. These applications are used both by individual consumers and enterprises in the healthcare; banking, financial services, a …
- 世界のメディカルニュートリション(栄養療法)市場動向（2012-2016）Introduction to the Market Medical or clinical nutrition is the nourishment or aliment given to people who are not able to obtain essential nutrients from ingested food or through body processes. Nutrition forms an important link between diet, health, and disease. The essential nutrients that a person should include in the diet are vitamins, carbohydrates, fats, proteins, and minerals in the requi …
- 世界のミサイル及びミサイル防衛システムの市場動向2013-2023：主な開発プロジェクトThis report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Missiles and Missile Defense Systems. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
